ISOCITRATE DEHYDROGENASE GENE MUTATION
Clinical trials for ISOCITRATE DEHYDROGENASE GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ISOCITRATE DEHYDROGENASE GENE MUTATION trials appear
Sign up with your email to follow new studies for ISOCITRATE DEHYDROGENASE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat blood cancers
Disease control TerminatedThis early-stage study tested a new oral drug called HMPL-306 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. The trial focused on patients whose ca…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC
-
First human test of new cancer pill halted early
Disease control TerminatedThis was an early-stage study to check the safety and find the right dose of an experimental pill called HMPL-306. It was for adults with advanced solid tumors that had a specific genetic change (IDH mutation) and had stopped responding to standard treatments. The study was termi…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC